ArticleFrontiers in medicine2021

Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells.

Yanjiao Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.